Research & Support

The following research material is made available for information purposes only. It may reflect indications
not yet approved in Canada.

VSL#3® is one of the few probiotic preparations supported by Level One scientific data (double-blind, placebo controlled studies). VSL#3® has been the subject of extensive clinical research in patients with ulcerative colitis, an ileal pouch, irritable bowel syndrome and several other clinical conditions.

Study 1

Ileal Pouch (Pouchitis) Studies

Review of data supporting VSL#3® for the care of patients with an ileal pouch.

Conditions such as ulcerative colitis, if severe enough, may require that patients have surgery to remove the colon.

Study 2

Ulcerative Colitis Studies

Ulcerative Colitis (UC) is a disease characterized by inflammation and ulceration of the inner lining of the colon and rectum. Symptoms may include diarrhea, abdominal discomfort, cramping, and an urgent need to have a bowel movement.

Study 3

Other Studies

The following are some of the original published articles and review papers on VSL#3®.

Going with His Gut Bacteria, Video: Interview with Dr. Fedorak, One on One with Professor Qasim Aziz and Dr. Linden Ruckert.